Parvovirus Vaccine, Modified Live Virus

Contents: This product contains the antigen listed above.
Gentamicin and thimerosal added as preservatives.
Indications: For vaccination of healthy dogs 6 weeks of age or older as an aid in the prevention of disease caused by canine parvovirus.
Dosage and Administration: Inject one 1 mL dose subcutaneously using aseptic technique. A recommended vaccination schedule should start at or about 6 weeks of age. The presence of maternal antibody is known to interfere with the development of active immunity. Puppies should be revaccinated every 2 to 3 weeks until 12 weeks of age. All dogs over 12 weeks of age should initially receive 1 dose of vaccine and a second dose 2 to 3 weeks later. Annual revaccination with one dose is recommended.
InfoVax-ID System: The InfoVax-ID System provides a simple and effective method of recording pertinent information on the vaccines administered to animals in a veterinary practice.For vaccines requiring reconstitution, remove label from both vials and affix both labels to the animal's medical chart.
Precaution(s): Store in dark at 2° to 7° C (35° to 45°F). Avoid freezing. Shake well. Burn container.
Caution(s): In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package. (9CFRPart 112.6)
In case of anaphylactoid reaction, administer epinephrine.
For use in dogs only.
Presentation: 25 doses (25 x 1 mL vials of vaccine), featuring the InfoVax-ID System.